Amanta Healthcare to Launch IPO on September 1 – Explained.

Ahmedabad-based Amanta Healthcare, a maker of parenteral products (IV fluids and injections), is coming out with its first IPO on September 1. The issue will be open till September 3, with anchor investors bidding on August 29. Listing is expected on September 8. Key details: • IPO size: Fresh issue of 1 crore equity shares, expected to raise ₹130–160 crore. • Earlier plan cut: Reduced from 1.25 crore shares, but objectives remain the same. • Use of funds: - ₹70 crore for civil construction at its Gujarat facility. - ₹30.13 crore for new machinery to expand SteriPort (large volume parenterals) and SVP (small volume parenterals) manufacturing. - Balance for general corporate needs. Why it matters: • Parenteral products are widely used in hospitals, pharma companies, and critical care, making it a steady-demand segment. • The IPO proceeds will directly fund expansion, which may boost production and market reach. • Being a fresh issue, all money raised goes into the company, not existing shareholders. • As the first mainboard IPO in September, it may draw attention from investors looking for new opportunities in the healthcare space. Summary: Amanta Healthcare’s IPO is focused on capacity expansion in IV fluids and injectables. With strong demand in healthcare and proceeds earmarked for growth, it adds another healthcare play to Dalal Street, offering investors exposure to a steady and essential segment of the pharma industry.